Home▸Bariatric Surgery vs Pharmacotherapy▸Combined Bariatric Surgery Plus GLP-1 Simulator

🏥 Combined Bariatric Surgery Plus GLP-1 Simulator

This simulator illustrates the combination of bariatric surgery with subsequent GLP-1 therapy.

Bariatric Surgery vs Pharmacotherapy2DModerate60 FPS
bariatric-surgery-plus-glp1-simulator ↗ Open standalone

Post-Bariatric Plateau — Placeholder Title

Short placeholder: surgery drives early loss then weight stalls.

  • 25%: Typical surgical loss (placeholder sub-caption)
  • ~12 mo: Plateau onset (placeholder sub-caption)
  • 20–30%: Regain risk (placeholder sub-caption)
  • ~1 in 4: Patients affected (placeholder sub-caption)

Why weight loss plateaus after surgery

Placeholder body text — short filler sentence.

Placeholder body text — short filler sentence.

Placeholder body text — short filler sentence.

Adding GLP-1 Therapy — Placeholder Title

Short placeholder: pharmacologic therapy layered onto surgical anatomy.

  • Semaglutide: GLP-1 agents used (placeholder sub-caption)
  • 0.25mg: Typical starting dose (placeholder sub-caption)
  • ~16 wk: Titration window (placeholder sub-caption)
  • Plateau/regain: Eligible candidates (placeholder sub-caption)

Appetite-suppression mechanism added

Placeholder body text — short filler sentence.

Placeholder body text — short filler sentence.

Restriction Plus Suppression — Placeholder Title

Short placeholder: two mechanisms act on appetite and intake simultaneously.

  • Restriction: Surgical mechanism (placeholder sub-caption)
  • Appetite axis: Pharmacologic mechanism (placeholder sub-caption)
  • GLP-1R: Receptor target (placeholder sub-caption)
  • ~1–2 mo: Onset of synergy (placeholder sub-caption)

How the two mechanisms interact

Placeholder body text — short filler sentence.

Placeholder body text — short filler sentence.

Extra Monthly Loss — Placeholder Title

Short placeholder: combined monthly loss exceeds either therapy alone.

  • ~8–10%: Added loss (6 mo) (placeholder sub-caption)
  • Mostly additive: Additive vs. synergistic (placeholder sub-caption)
  • Reduced: Plateau resistance (placeholder sub-caption)
  • Monthly: Follow-up cadence (placeholder sub-caption)

Tracking the additive trajectory

Placeholder body text — short filler sentence.

Placeholder body text — short filler sentence.

Total Trajectory vs. Plateau — Placeholder Title

Short placeholder: combined outcome compared to surgery-alone plateau.

  • ~35–40%: Combined total loss (placeholder sub-caption)
  • ~25%: Surgery-alone plateau (placeholder sub-caption)
  • +10–15%: Net gain from GLP-1 (placeholder sub-caption)
  • Sustained: Durability (placeholder sub-caption)

Comparing combined vs. surgery-alone outcomes

Placeholder body text — short filler sentence.

Placeholder body text — short filler sentence.

⚙ Under the hood

This simulator illustrates the combination of bariatric surgery with subsequent GLP-1 therapy.

CanvasBiomedicine

2D · HTML5 Canvas 2D · 60 FPS target · runs fully client-side, no install

What did you find?

Add reproduction steps (optional)